Late-stage biopharma developing a treatment for GERD
| Date | Round | Amount |
|---|---|---|
| May 2022 | Funding round Stockholm biotech Cinclus Pharma raised about EUR22M in a private placement led by Trill Impact to accelerate commercialisation. | $23.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.